Now at 89 i'm a former poster on SA..
82 years of trading and 65 owning my own firm..
I've lived through WW2 and other bad situations in countries before I arrived in the US.
And this situation on SA has become something that has no place in the USA ~!
This used to be a great place for open chat and a great place to get valuable views on the market. Now, the site is a commercial crap trap site run by left wing progressive slime ! Nazi~like lowlifes who censor the most bizarre stuff .And, now they just found themselves a survey that hints at their view and sent me a link. #@(^!+*** ( scatological barrage)
Many of you have my personal email addresses and feel free to use them. I will always do my best concerning the market.And, if I don't know about your symbol or subject I will say so..
Pura vida amigos/amigas
I am an active investor in IP-centric investments for 5 years. I specialize in high risk / high reward situations both public and private. It is important for investors to plan for all outcomes as the litigation surrounding the IP investment takes many twists and turns. Extracting profits and limiting exposure are the keys to success.
I hope to provide information and strategies, which both expert and novice IP investors can profit from.
Follow me on twitter for the latest updates in the IP space:
I am a Portuguese independent trader, analyst and algorithmic trading expert, having worked for both sell side (brokerage) and buy side (fund management) institutions.
I've been trading professionally for about 20 years and also launched www.thinkfn.com in 2004. Thinkfn (Think Finance) carries thousands of educational articles on finance and the markets.
I trade futures, stocks from the long and short side, forex and options. I trade both discretionary and fully automated systems (Metatrader, Quantshare and others).
I can be reached at paulo.santosATthinkfn.com or followed on Twitter at twitter.com/ThinkFinance999
Trading over 12 years, with an emphasis in small cap biotech. Passionate about science and cooking.
"Win or lose, everybody gets what they want out of the market. Some people seem to like to lose, so they win by losing money."
I am a software engineer by profession. Got interested in market analysis some time back and now I spend most of my free time researching equities. .
I am also a freelance financial writer , investor and consultant. I primarily look for market inefficiencies to generate long term alpha irrespective of holding time and sector.
Studied: Power Engineering, Exploration Technology, Worked Upstream, Midstream, Downstream in Oil and Gas, Pipelines, Drilling, Refineries. Regardless of our desire for clean energy, oil makes things and is the building block of any economy. From production to transport to refining its the lifeblood of our lifestyle and we will likely pay more for it in the future as the USD looses its advantage as the worlds only reserve currency. The USD has likely peaked and will soon rollover and as it does the commodities will see a boom over several years.
I'm Interested in very big picture, game changers that come from sizeable economic deposits
of Oil, Gas, Gold, Silver, Uranium, Specialty Metals used in supplying Energy Infrastructure.
Anything dubbed "EXPLORATION" should always be considered high "RISK" Capital and never larger than a single digit % of your entire portfolio. (Please re-read that sentence, its important)
I don't offer investment advice, I generate compelling ideas that if they were to work out as promoted 'could' offer returns above average.
The caveat being that exploration in gold, oil, silver, uranium, rarely nets a commercial operation that pays shareholders back, so you can trade them, and speculate in them, but don't count on them to save you as they are only intended as a low % holding that has good risk/reward return if the thesis works out.
Your odds might be 2/100 for gold exploration, 3/100 for oil, so keep that in mind before plunking down your life savings. I try to weed out stories that have no hope, and shortlist ones that do.
Focus areas; Oilsands, Oil Shale in North Dakota, Natural Gas in Canada, Colorado, Texas, North Island New Zealand, Australia, Uranium in Saskatchewan, Texas. Metals Mining in Nevada, British Columbia, Mexico. Thorium as a substitute for Uranium. Oil Exploration in proven formations in WSCB, Colorado, West Texas, Southern Saskatchewan, North Dakota, and select riskier emerging locations in Africa, Albania, Colombia, Argentina.
Hydraulic Fracturing, Frac Sand Technologies, Oil Well Services and Horizontal Drillers. Natural Gas fired power plants and infrastructure, LNG Infrastructure, Terminals, LNG Shipping (LNG Shipping, Pipelines. North American OIL Pipelines, to and from Oilsands Producers, Refineries. OIL deposits organized by basin, geological name, or reserve size.
Operate a startup blog called Tullii.org which aims to summarize the above topics using info graphics and charts for the layperson interested in adding oil and gas investments with a 2-3 year horizon.
I approach from the Basin upward, do consult your own advisors before spending a dime on any of my ideas presented here. Remember I am just some guy you found on the internet, so do your own homework before you trade and be 100% responsible for your own risks and rewards. I repeat Most of what I present should only ever be 1-5% or less of your portfolio as its mostly unproven exploration projects nearing completion of validating reserves or resources.
That being said I try to filter the projects by their upside potential with an emphasis on 'potential' to beat traditional investments if the story turns to fact via the drillbit.
We are a tax consulting and company formation firm located offshore in the sunny, tax free Bahamas since 1990. I've formed over 1,030 Bahamian IBCs and 360 Anguilla IBCs since 1990.
◾Anguilla is a UK overseas territory with same tax status as Cayman Islands.
◾All the money and technology to create their offshore registration services came out of London.
◾Anguilla was one of the very first tax havens that adopted an online registry service.
◾QEII is the head of State.
◾Got questions? email firstname.lastname@example.org
The Caribbean tax havens have grown to rival New York and London as a place to hold family assets, and the US FET is one reason why there are so many offshore companies there.
480,000 IBCs in BVI;
100,000 “exempt companies” in Cayman;
45,000 IBCs in the Bahamas;
30,000 cos in Bermuda
25,000 IBCs in Anguilla
None of the Caribbean (tax) havens levy an estate tax.
Nobody is much interested in tax avoidance any more, so I'm posting Tom's Fishing Gallary pictures instead http://bahamasbahamas.com/images/gallery.html
Personal info here https://www.linkedin.com/profile/preview?locale=en_US&trk=prof-0-sb-preview-primary-button
and PFIC / FATCA info for planners https://www.linkedin.com/pulse/new-irs-form-8938-created-fatca-2010-can-filing-avoided-tax-havens?trk=prof-post
JPMorgan/Chase writes on U.S. Estate taxation: "Because stock of a foreign corporation (in a no tax haven) is not subject to U.S. estate tax, holding U.S. situs assets through a foreign corporation constitutes a planning opportunity." http://www.jpmfinancialservices.com/images/PDFs/EstateTaxation.pdf
I started investing while getting my Ph.D. at McGill University. My research was on behavioral correlates of neurological control of cardiovascular function. After 25 years as a Professor, I quit to do something more exciting and more difficult: live off of my investments. For quite some time, I specialized in Canadian Oil & Gas Trusts, other high income opportunities and special situations. In 2005, I founded the Trust Intelligence website to provide research and guidance to investors trying to wean them off of relying on sell-side analysts and to understand how to do due diligence from the point of view of an investor.
My personal investment focus, and that on my website, is still on special situations and income investments in Canada and the USA. I am focused on looking at relative value and great managements with businesses that have the characteristics to give them superior potential. While I retain interesting in the petroleum & income sectors I not focus on a few biotech special situations because they can be transformative for people's health and their net worth.
Editor for The Biotech Forum, the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade.
Please go to biotechforumsa.com for more on the Biotech Forum service available through SeekingAlpha. For Free Investment Reports on a variety of topics go to bretjenseninvests.com
I have a private small company with a few different revenue streams. I survive off of one particular stream and invest the other smaller streams into the market.
I consider myself a longterm value investor and am not risk averse. I have three seperate portfolios each holding one third of my capital.
My goal was to create a multiframed method of analysis that might allow the average retail investor to pick investments that have a high probability of doubling or tripling. I am willing to cut against the grain and take contrarian deep value bets based on price value inefficiencies. I would like to compound at 30% average yearly gains in an all of my accounts. I have had 2 years of compounding my money at over 300% in these accounts so I would be ahead of my current benchmarks. As of end of 2013.
However, I do not expect to be able to repeat my results over the long term by trading. In fact I expect to sometimes underperform the market as many of my ideas might take time to come to fruition. I will often use arbitrage opportunities or short term swings for smaller gains. I am working on fine tuning my methodology but I believe it is unique and should produce the minimum average of 30%. I am currently ahead in this race and can withstand a correction as my portfolio grows quickly. I am also willing to get defensive if need be to protect capital or even go 50%cash. I run this as a very concentrated portfolio.
One third of my capital goes in a DRIP that I average in monthly to seven companies. I change these companies yearly based on valuation and position size. I grow positions here over time and never want to hold more than 30 companies in this account.
One third goes into long term companies that I see huge growth potential.
One third is in speculative bio-tech, tech and just about anything else where I can understand the financial statement sheets on and has great possible momentum and catalysts.
I often find myself going against the current trends in the market as I see opportunity in others fear. That said I seem to invest in around 15 stocks at a time and try to focus investments into the company at the best value. I hope to earn a healthy return over the next ten years to twenty years.
I am also interested in working in the industry as a career change and am always open to advice. Anyone out there want a 36 year old intern with advanced degrees in other areas?
My main skills are finding deep value opportunities and lucrative swing trade opportunities. I seem to have found a lot of bottom entries even in today's markets. I am willing to learn, enjoy games/game theory, love to read and solve problems.
I am working on starting a limited partnership for 2015 or 2016 so that I can share my gifts with family and friends.
"What looks like a horrible disaster now could be an awesome opportunity." "Buy Cheap when the big funds and others are giving it away"
All the Best,
David Moenning is Chief Investment Officer at Sowell Management Services, a registered investment advisor with more than $500 million under management. Sowell emphasizes an MPD (Modern Portfolio Diversification) approach to portfolio design which diversifies client holdings not only across asset classes but also by strategy, manager, and investment methodology. Dave began his investment career in 1980 and has been an independent money manager since 1987. Thus, Dave has been live on the firing line and investing for a living for nearly 30 years.
I approach investing as a social theorist and a cultural historian. As a result, I am a contrarian. Studying the history of financialization, I have to agree with value investors like Seth Klarman, George Soros, and John Quiggin that markets are ultimately inefficient. However, I am not an orthodox value-investor. I believe in diversified strategy so as to insure maximum gains while maintaining a "margin of safety." Understanding that markets will operate inefficiently, I sometimes find "playing the greater fool's game" will yield nice short term gains. I have been investing for five years and have had proven results. I offer unique insight on fundamentals that most analysts do not consider.
Cornelius Vanderbilt has done more than any other man to shape our idea of investing. He was the ultimate contrarian. As an investor he looked for both value and risk. His approach to markets is complex and contradictory but can be learned from.
B.A., NYU Gallatin School
M.A. CUNY Gradatuate Center [in progress]
I started a twitter. https://twitter.com/matt_finston
In evaluating investment opportunities, I consider a company's management, products, customer relationships, competitive positioning, financials, the macroeconomic climate, social media response and other sources.
I arrive at my own conclusions, tuning out the noise of the marketplace. My investment choices are typically based on a holding period of at least two to three years. Influences include Nassim Nicholas Taleb, Howard Marks, Joel Greenblatt, Steve Romick and Warren Buffett. My academic studies were in literature and psychology; I've supplemented this with extensive reading in business, economics and investing.
I'm a value investor focused on buying companies trading below the intrinsic value.
I've a back ground in engineering & finance. I'm also a Chartered Financial Analyst. I did my MBA from Emory University's Goizueta School of Business
Andy Blinston is the founder of Investing Sidekick, a website that provides stock reports and analytical spreadsheets for investors. He has been working as a research analyst for 10 years and aims to share his analysis and insights with private investors.
For the past 30 years, I have been involved in startups, as a founder, and active investor. My first company was purchased by Johnson & Johnson, which set the foundation for future investments.
My level of trading escalated after graduating from college, primarily as a result of my relationship with the founder of the Silicon Valley venture capital firm, Institutional Venture Partners, (Netflix, Twitter, Oracle). By focusing on VC backed companies, I soon learned the advantage of investing in promising companies before they became household names. My interest in startups has never waned, and has become my primary focus today.
Dividends - Core:
DOW / CE / O / MO / OHI
Speculative - Growth:
GLUU / MATR / JAKK / RMTI
(as of 09/11/14)
Main goal; not waiting for retirement, live now with the benefits you earned and share it with loved ones.
I have a Bachelors Degree In Business Administration. I have been investing in biotech stocks for many years, and I prefer to invest as a long term investor. With that In mind I seek stocks that have long term value! I primarily Like to Invest In biotechnology stocks and I accept the risks.
I Write for the Healthcare Sector and Stock market in general. I contribute to Seeking Alpha, Talk Markets, and CNA Finance. I run my own biotechnology website Biotechpicklist.com and in addition I post stock market news on my other website Wallstreetrain.com
Former hedge fund trader with +10 years experience as a professional trader. Recipient of the "Trader of the Year Award" in 2008. Acted as junior Portfolio Manager for a fund with an estimated $450 million under management.
I enjoy writing articles, it's the best way to organize my ideas and helps me come to a conclusion about a specific investment or trade. I share my analysis with others because we're all in this game together.
Check out my professional profile and connect with me on LinkedIn. http://lnkd.in/ingcSe
I am an independent equity research analyst and consultant. I focus on finding small-cap biotech stocks where I believe there is favorable risk / reward because of misinformation, lack of information, or a potential fundamental turnaround. I provide detail analysis for investors and investor relations companies. I also provide due diligence and advisory services to companies. Some names I write on I invest in personally and will disclose my position. Names that have hired me to provide due diligence or advisory services I will disclose a business relationship. I previously worked for Zacks Investment Research from 2003 to 2015 as a Senior Biotechnology Analyst. Prior to Zacks, I spent 1999 to 2002 managing money with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology. Prior to joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases, between 1995 and 1998. I also spent a year working at the Fralin Biotechnology Center, and a year working for a cancer researcher while at Virginia Tech. I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University. I hold the Chartered Financial Analyst (CFA) designation.
The reports that I write are my personal research and opinions. They are not associated with any firm or organization, and are not intended to be taken as investment recommendations or advice. They combine my passions of economics, finance, writing and education, and are intended mostly as educational material. I attempt to write the articles in an easy to understand down to earth style in an effort to help others with their research. This is my effort to bring understandable and educational professional quality research to the public at large free of charge.
General Disclaimer for my Articles:
BS Business, Majored in Finance and Economics, Miami University
MA Economics w/ Managerial and International Emphasis, University of Oklahoma
Past: Economics and Finance Instructor at various Universities
Past: Mutual Fund Portfolio Manager of Family of Mutual Funds
Past: CIO of Mid-Sized Investment Management Firm
Professional: CFA Charterholder
Please note that the content of this site should not be construed as investment advice, nor do the opinions expressed necessarily reflect the views of CFA Institute.
Full Time Micro Cap Investor. Founder of MicroCapClub.com
Founded in 2011, MicroCapClub is an exclusive forum for experienced microcap investors focused on microcap companies (sub $300m market cap). MicroCapClub was created to be a platform for experienced microcap investors to share and discuss stock ideas. MicroCapClub’s mission is to foster the highest quality microcap investor Community, produce Educational content for investors, and promote better Leadership in the microcap arena.
Lares Capital, a long/short fund that specializes in small caps, option strategies, and low-liquidity equities. The fund invests in both domestic and foreign securities.
You can contact us at email@example.com.
Tom Shaughnessy is owner of SecretCaps.com, an independent investor and analyst. He has been investing in the stock market since the age of twelve. His style is comprehensive and includes multi-layered research on a concentrated set of stocks. Tom enjoys constructive dialogue regarding various investment ideas and theories.
Tom enjoys intensive research on prospective investments. This includes valuation estimates and modeling, CEO and management interviews, product and expansion overviews, future prospects, financial analysis and the current state of affairs at the company. Moreover, Tom's articles have a focus on micro-cap companies whose potential have flown under the radar.
In his leisure time Tom enjoys playing racquetball on a competitive level.